A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Hoffmann, Markus, Kleine-Weber, Hannah, Pöhlmann, Stefan·2020·Molecular Cell
DOI 10.1016/j.molcel.2020.04.022

Cited by (1,004)

Items 501–600 of 1,004

  1. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
    Joyce van de Leemput, Zhe Han · 2021 · Molecular and Cellular Biology
  2. Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies
    Huyen Tran Ho, Stefan Peischard, Nathalie Strutz‐Seebohm, Karin Klingel, Guiscard Seebohm · 2021 · Viruses
  3. Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity
    Yvan Butera, Enatha Mukantwari, Maria Artesi, Jeanne d’Arc Umuringa, Áine O’Toole, Verity Hill, Stefan Rooke, Samuel Leandro Hong, Simon Dellicour, Onesphore Majyambere et al. · 2021 · Nature Communications
  4. VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
    Wasim Aluísio Prates-Syed, Lorena C. S. Chaves, Karin P. Crema, Larissa Vuitika, Aline Aparecida de Lima Lira, Nelson Côrtes, Victor Kersten, Francisco Eduardo Gontijo Guimarães, Mohammad Sadraeian, Fernando Luís Barroso da Silva et al. · 2021 · Vaccines
  5. SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade
    Firdaus Samsudin, Palur Venkata Raghuvamsi, Ganna Petruk, Manoj Puthia, Jitka Petrlová, Paul A. MacAry, Ganesh S. Anand, Peter John Bond, Artur Schmidtchen · 2022 · Journal of Molecular Cell Biology
  6. Antigenic evolution of SARS coronavirus 2
    Anna Z. Mykytyn, Ron A. M. Fouchier, Bart L. Haagmans · 2023 · Current Opinion in Virology
  7. Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone
    Peter J. Siska, Sonja-Maria Decking, Nathalie Babl, Carina Matos, Christina Bruss, Katrin Singer, Jana Klitzke, Marian Schön, Jakob Simeth, Josef Köstler et al. · 2021 · Journal of Clinical Investigation
  8. Targeting Crucial Host Factors of SARS-CoV-2
    Anil Mathew Tharappel, Subodh Kumar Samrat, Zhong Li, Hongmin Li · 2020 · ACS Infectious Diseases
  9. Single-Molecule FRET Imaging of Virus Spike–Host Interactions
    Maolin Lu · 2021 · Viruses
  10. Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
    Pui Wang, Siu-Ying Lau, Shaofeng Deng, Pin Chen, Bobo Wing-Yee Mok, Jinxia Zhang, Andrew Chak-Yiu Lee, Kwok‐Hung Chan, Rachel Chun-Yee Tam, Haoran Xu et al. · 2021 · Nature Communications
  11. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2
    Raymond R. R. Rowland, Alberto Brandariz-Núñez · 2021 · Microbiology Spectrum
  12. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay
    Kanokporn Polyiam, Waranyoo Phoolcharoen, Namphueng Butkhot, Chanya Srisaowakarn, Arunee Thitithanyanont, Prasert Auewarakul, Tawatchai Hoonsuwan, Marasri Ruengjitchatchawalya, Phenjun Mekvichitsaeng, Yaowaluck Maprang Roshorm · 2021 · Scientific Reports
  13. Point-of-Care Testing—The Key in the Battle against SARS-CoV-2 Pandemic
    Florina Silvia Iliescu, Ana Maria Ionescu, Larisa Gogianu, Monica Simion, Violeta Dediu, Mariana Carmen Chifiriuc, Grațiela Grădișteanu Pîrcălăbioru, Ciprian Iliescu · 2021 · Micromachines
  14. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy
    Harry F. Ridgway, Christos T. Chasapis, Konstantinos Kelaidonis, Irene Ligielli, Graham J. Moore, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, Thomas Mavromoustakos, John Matsoukas · 2022 · Viruses
  15. COVID-19 and Parkinsonism: A Critical Appraisal
    Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, Eleonora Del Prete, Sara Meoni, Sara Grisanti, Marialuisa Zedde, Rosario Pascarella, Elena Moro, Franco Valzania · 2022 · Biomolecules
  16. Evolutionary remodelling of N‐terminal domain loops fine‐tunes SARS‐CoV‐2 spike
    Diego M. Cantoni, Matthew J Murray, Mphatso D. Kalemera, Samuel J. Dicken, Lenka Stejskal, Georgina Brown, Spyros Lytras, Jonathon D. Coey, James Patrick McKenna, Stephen Bridgett et al. · 2022 · EMBO Reports
  17. SARS-CoV-2 variants: Impact on biological and clinical outcome
    Shakuntala Mahilkar, Sachee R Agrawal, Sakshi Chaudhary, Swapneil Parikh, Subash Chandra Sonkar, Dileep Kumar Verma, Vidushi Chitalia, Divya Mehta, Bidhan Chandra Koner, Neetu Vijay et al. · 2022 · Frontiers in Medicine
  18. Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19
    Bismark Dankwa, Emmanuel Broni, Kweku S. Enninful, Samuel K. Kwofie, Michael D. Wilson · 2022 · Structural Chemistry
  19. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19
    Man Wang, Wenguang Chang, Lei Zhang, Yuan Zhang · 2022 · International Journal of Biological Sciences
  20. Host range, transmissibility and antigenicity of a pangolin coronavirus
    Yixuan Jacob Hou, Shiho Chiba, Sarah R. Leist, Rita M. Meganck, David R. Martinez, Alexandra Schäfer, Nicholas Catanzaro, Vishwaraj Sontake, Ande West, C.E. Edwards et al. · 2023 · Nature Microbiology
  21. GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies
    Ching‐Yuan Wu, Yu‐Shih Lin, Yao‐Hsu Yang, Li‐Hsin Shu, Yu‐Ching Cheng, Hung Te Liu · 2020 · Biomedicine & Pharmacotherapy
  22. Good Cholesterol Gone Bad? HDL and COVID-19
    George Eduardo Gabriel Kluck, Jeong‐Ah Yoo, Emmanuel H. Sakarya, Bernardo L. Trigatti · 2021 · International Journal of Molecular Sciences
  23. L‐lysine: Its antagonism with L‐arginine in controlling viral infection. Narrative literature review
    Maria Cristina Pedrazini, Mariliza Henrique da Silva, Francisco Carlos Groppo · 2022 · British Journal of Clinical Pharmacology
  24. SARS‐CoV‐2 biology and variants: anticipation of viral evolution and what needs to be done
    R. Luo, Agnès Delaunay-Moisan, K. Timmis, A. Danchin · 2021 · Environmental Microbiology
  25. SARS-CoV-2 Omicron spike H655Y mutation is responsible for enhancement of the endosomal entry pathway and reduction of cell surface entry pathways
    Mizuki Yamamoto, Keiko Tomita, Youko Hirayama, Jun‐ichiro Inoue, Yasushi Kawaguchi, Jin Gohda · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  26. SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms
    Jiaqi Li, Huimin Jia, Miaomiao Tian, Nijin Wu, Xia Yang, Jianni Qi, Wanhua Ren, Feifei Li, Hongjun Bian · 2022 · Frontiers in Cellular and Infection Microbiology
  27. SARS-CoV-2 another kind of liver aggressor, how does it do that?
    Sonia Amelia Lozano-Sepúlveda, Kame A. Galán-Huerta, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Ana María Rivas-Estilla · 2020 · Annals of Hepatology
  28. Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein
    Zhadyra Mustafa, Anuar Zhanapiya, Hubert Kalbacher, Timo Burster · 2021 · ACS Omega
  29. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
    Hataf Khan, Helena Winstone, Jose M. Jiménez-Guardeño, Carl Graham, Katie J. Doores, Caroline Goujon, David A. Matthews, Andrew D. Davidson, Suzannah J. Rihn, Massimo Palmarini et al. · 2021 · PLoS Pathogens
  30. Peptide-Based Vaccines and Therapeutics for COVID-19
    Pritam V. Bagwe, Priyal Bagwe, Sai Srinivas Ponugoti, Shreerang V. Joshi · 2022 · International Journal of Peptide Research and Therapeutics
  31. Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
    Théophile Cocherie, Karen Zafilaza, Valentin Leducq, Stéphane Marot, Vincent Cálvez, Anne‐Geneviève Marcelin, Ève Todesco · 2022 · Microorganisms
  32. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics
    Gyanendra Bahadur Chand, Atanu Banerjee, Gajendra Kumar Azad · 2020 · Gene Reports
  33. Non-coding RNAs expression in SARS-CoV-2 infection: Pathogenesis, clinical significance and therapeutic targets
    Xiaoxing Liu, Wandi Xiong, Maosen Ye, Tangsheng Lu, Kai Yuan, Suhua Chang, Ying Han, Yongxiang Wang, Lin Lü, Yanping Bao · 2023 · Signal Transduction and Targeted Therapy
  34. Overview of host-directed antiviral targets for future research and drug development
    Xiaoxia Gu, Mengzhu Zheng, Ya Ming Gao, Shuang Jun Lin, Xiaotian Zhang, Chunmei Chen, Hucheng Zhu, Weiguang Sun, Yonghui Zhang · 2025 · Acta Pharmaceutica Sinica B
  35. Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion
    Lele Cui, Yongsheng Cui, Jing Liu, Wei Li, Mengdan Wu, Xiawei Wei, Ying Lai, Peng Mi · 2025 · Nature Communications
  36. A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection
    Antoine Fakhry AbdelMassih, Jianping Ye, Aya Kamel, Fady Mishriky, Habiba‐Allah Ismail, Heba Amin Ragab, Layla El Qadi, Lauris Malak, Mariam Abdu, Miral El-Husseiny et al. · 2020 · Obesity Medicine
  37. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm
    Xiang Peng, Yani Wang, Xiangwen Xi, Ying Jia, Jiangtian Tian, Bo Yu, Jinwei Tian · 2021 · Cardiovascular Drugs and Therapy
  38. Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2
    Yejin Jang, Jin Soo Shin, Myoung Kyu Lee, Eunhye Jung, Timothy An, Uk-Il Kim, Kyungjin Kim, Meehyein Kim · 2021 · International Journal of Molecular Sciences
  39. The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
    Johnny S. Younis, Karl L. Skorecki, Zaid A. Abassi · 2021 · Frontiers in Endocrinology
  40. Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants
    Danwei Yu, Yuanmei Zhu, Tao Jiao, Tong Tong Wu, Xia Xiao, Bo Qin, Huihui Chong, Xiaobo Lei, Lili Ren, Sheng Cui et al. · 2021 · Emerging Microbes & Infections
  41. The Spike of SARS-CoV-2: Uniqueness and Applications
    Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flávia Figueira Aburjaile, Athira Ch, Diego Lucas Neres Rodrigues, Sandeep Tiwari, Khalid Jamaan Alzahrani, Aristóteles Goés‐Neto et al. · 2021 · Frontiers in Immunology
  42. SARS-CoV-2 and pathological matrix remodeling mediators
    Imen Guizani, Nesrine Fourti, Wiem Zidi, Moncef Feki, Monia Elasmi · 2021 · Inflammation Research
  43. The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City
    Alberto Cedro‐Tanda, Laura Gómez-Romero, Nicolás Alcaraz, Guillermo de Anda‐Jáuregui, Fernando Peñaloza, Bernardo Moreno, Marco A. Escobar-Arrazola, Oscar A. Ramirez-Vega, Paulina Munguía-Garza, Francisco Garcia-Cardenas et al. · 2021 · Viruses
  44. Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro
    Binli Mao, Vu Thuy Khanh Le‐Trilling, Kai Wang, Denise Mennerich, Jie Hu, Zhenyu Zhao, Jiaxin Zheng, Yingying Deng, Benjamin Katschinski, Shilei Xu et al. · 2022 · Emerging Microbes & Infections
  45. A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease
    Lisa Douglas, James A Reihill, Melisa W-Y. Ho, Jeffrey M. Axten, Nino Campobasso, Jessica L. Schneck, Alan R. Rendina, Keith Wilcoxen, Lorraine Martin · 2022 · Cell chemical biology
  46. Endomembrane remodeling in SARS-CoV-2 infection
    Di Chen, Yan G. Zhao, Hong Zhang · 2022 · Cell Insight
  47. Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii
    Anna Maria Kiefer, Justus Niemeyer, Anna Probst, Gerhard Erkel, Michael Schroda · 2022 · Frontiers in Plant Science
  48. Global Diversification and Distribution of Coronaviruses With Furin Cleavage Sites
    Liu, Xiaotong, Wu, Qunfu, Zhang, Zhigang · 2021 · Frontiers in Microbiology
  49. Assessing COVID-19 Susceptibility Through Analysis of the Genetic and Epigenetic Diversity of ACE2-Mediated SARS-CoV-2 Entry
    Georgia Ragia, Vangelis G. Manolopoulos · 2020 · Pharmacogenomics
  50. Structural understanding of SARS-CoV-2 virus entry to host cells
    Kim Phuong Uyen Le, Shrute Kannappan, Truc Kim, Jung Heon Lee, Hye-Ra Lee, Kyeong Kyu Kim · 2023 · Frontiers in Molecular Biosciences
  51. Repositioning microbial biotechnology against COVID‐19: the case of microbial production of flavonoids
    Tobias Goris, Álvaro Pérez‐Valero, Igor Martínez, Dong Yi, Luis Fernández‐Calleja, David San León, Uwe T. Bornscheuer, Patricia Magadán‐Corpas, Felipe Lombó, Juan Nogales · 2020 · Microbial Biotechnology
  52. Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins
    H. Weisshoff, Oxana O. Krylova, Heike Nikolenko, Hans‐Dirk Düngen, André Dallmann, Susanne Becker, Peter Göttel, Johannes Müller, Annekathrin Haberland · 2020 · Heliyon
  53. Population Dynamics and Structural Effects at Short and Long Range Support the Hypothesis of the Selective Advantage of the G614 SARS-CoV-2 Spike Variant
    Emiliano Trucchi, Paolo Gratton, Fabrizio Mafessoni, Stefano Motta, Francesco Cicconardi, Filippo Mancia, Giorgio Bertorelle, Ilda D’Annessa, Daniele Di Marino · 2020 · Molecular Biology and Evolution
  54. A risk marker of tribasic hemagglutinin cleavage site in influenza A (H9N2) virus
    Jiahao Zhang, Kaixiong Ma, Bo Li, Yiqun Chen, Ziwen Qiu, Jinchao Xing, Jinyu Huang, Chen Hu, Yifan Huang, Huanan Li et al. · 2021 · Communications Biology
  55. Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization
    Alexandru Adrian Hennrich, Bevan Sawatsky, Rosalía Santos-Mandujano, Dominic H. Banda, Martina Oberhuber, Anika Schopf, Verena Pfaffinger, Kevin Wittwer, Christiane Riedel, Christian Karl Pfaller et al. · 2021 · PLoS Pathogens
  56. A weak COPI binding motif in the cytoplasmic tail of SARS‐CoV‐2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization
    Benjamin C. Jennings, Stuart A. Kornfeld, Balraj Doray · 2021 · FEBS Letters
  57. ACE2, B0AT1, and SARS-CoV-2 spike protein: Structural and functional implications
    Yuanyuan Zhang, Renhong Yan, Qiang Zhou · 2022 · Current Opinion in Structural Biology
  58. Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2
    Samuel J. Dicken, Matthew J Murray, Lucy Thorne, Ann‐Kathrin Reuschl, Calum Forrest, Maaroothen Ganeshalingham, Luke Muir, Mphatso D. Kalemera, Machaela Palor, Laura E. McCoy et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  59. L-arginine: its role in human physiology, in some diseases and mainly in viral multiplication as a narrative literature review
    Maria Cristina Pedrazini, Elizabeth Ferreira Martinez, Victor Augusto Benedicto dos Santos, Francisco Carlos Groppo · 2024 · Future Journal of Pharmaceutical Sciences
  60. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19
    Gourab Das, Troyee Das, Nilkanta Chowdhury, Durbadal Chatterjee, Angshuman Bagchi, Zhumur Ghosh · 2020 · Genomics
  61. Possible Therapeutic Use of Natural Compounds Against COVID-19
    Nabab Khan, Xuesong Chen, Jonathan D. Geiger · 2021 · Journal of Cellular Signaling
  62. Role of SARS-CoV-2 and ACE2 variations in COVID-19
    Priya Antony, Ranjit Vijayan · 2021 · Biomedical Journal
  63. Inhibitory effect on SARS‐CoV‐2 infection of neferine by blocking Ca2+‐dependent membrane fusion
    Yang Yang, Peng Yang, Cong Huang, Yuming Wu, Zhe Zhou, Xuejun Wang, Shengqi Wang · 2021 · Journal of Medical Virology
  64. Single domain shark VNAR antibodies neutralize SARS‐CoV‐2 infection in vitro
    Aziz Gauhar, Cyril V. Privezentzev, Mykhaylo Demydchuk, Tanja Gerlza, Julia Rieger, Andreas J. Kungl, Frank S. Walsh, Julia Lynn Rutkowski, Paweł Stocki · 2021 · The FASEB Journal
  65. SARS CoV-2 Delta variant exhibits enhanced infectivity and a minor decrease in neutralization sensitivity to convalescent or post-vaccination sera
    A. Kuzmina, Seraj Wattad, Y. Khalaila, A. Ottolenghi, B. Rosental, Stanislav Engel, Elli Rosenberg, R. Taube · 2021 · iScience
  66. A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2
    Kasi Pandima Devi, Mahmoud Reza Pourkarim, Marijn Thijssen, Antoni Sureda, Maryam Khayatkashani, Cosmin Andrei Cismaru, Ioana Berindan Neagoe, Solomon Habtemariam, Soha Razmjouei, Hamid Reza Khayat Kashani · 2022 · Pharmacological Reports
  67. Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
    A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, Fabrizio Mancini, Roger Clemens, Aman Wirakartakusumah, Hui‐Fang Chiu, Chi‐Hua Yen, Sebastiano Porretta, Issac Mathai et al. · 2024 · npj Science of Food
  68. Clinical challenges of SARS‑CoV‑2 variants (Review)
    Cristian Cojocaru, Elena Cojocaru, Adina Turcanu, Dragos Cosmin Zaharia · 2022 · Experimental and Therapeutic Medicine
  69. A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications
    Jacob Schön, G. Tuba Barut, Bettina Salome Trüeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna Nicole Kelly, Melanie Brügger, Claudia Wylezich et al. · 2024 · Nature Microbiology
  70. Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections
    Qiongqiong Angela Zhou, Junko Kato-Weinstein, Yingzhu Li, Yi Deng, Roger Granet, Linda V. Garner, Cynthia Liu, Dmitrii A. Polshakov, Chris Gessner, Steven Watkins · 2020 · ACS Pharmacology & Translational Science
  71. SARS-CoV-2: Zoonotic origin of pandemic coronavirus
    Štefan Vilček · 2020 · Acta Virologica
  72. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes
    Yvonne Adu-Agyeiwaah, Maria B. Grant, Alexander G. Obukhov · 2020 · Cells
  73. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages
    Umesh Kalathiya, Monikaben Padariya, Robin Fåhræus, Soumyananda Chakraborti, Ted R. Hupp · 2021 · Biomolecules
  74. Antimicrobial Peptides and Physical Activity: A Great Hope against COVID 19
    Sonia Laneri, Mariarita Brancaccio, Cristina Mennitti, Margherita-Gabriella De Biasi, Maria Elena Pero, Giuseppe Pisanelli, Olga Scudiero, Raffaela Pero · 2021 · Microorganisms
  75. Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains
    Yuan Tian, Lisa M. Parsons, Ewa Anita Jankowska, John F. Cipollo · 2021 · Frontiers in Chemistry
  76. Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion
    Chia‐Jung Li, Tai‐Ling Chao, Ting-Yu Chang, Chia-Chun Hsiao, De-Chao Lu, Yi-Wei Chiang, Guan-Chun Lai, Ya‐Min Tsai, Jun‐Tung Fang, Si‐Man Ieong et al. · 2022 · Microbiology Spectrum
  77. Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence
    Anna Riccio, Silvia Santopolo, Antonio Rossi, Sara Piacentini, Jean‐François Rossignol, M. Gabriella Santoro · 2022 · Cellular and Molecular Life Sciences
  78. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections
    Ebba Rosendal, Ionut Sebastian Mihai, Miriam Becker, Debojyoti Das, Lars Frängsmyr, Björn David Persson, Gregory D. Rankin, Remigius Gröning, Johan Trygg, Mattias N.E. Forsell et al. · 2022 · mBio
  79. Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
    Raahilah Zahir Essa, Yuan Seng Wu, Kalaivani Batumalaie, Mahendran Sekar, Chit Laa Poh · 2022 · Pharmacological Reports
  80. The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation
    Chenxu Guo, Shang Jui Tsai, Yiwei Ai, Maggie Li, Andrew S Pekosz, Andrea Cox, Nadia A. Atai, Stephen J. Gould · 2022 · Science Advances
  81. SARS-CoV-2 and the host-immune response
    David P. Maison, Youping Deng, Mariana Gerschenson · 2023 · Frontiers in Immunology
  82. Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants
    Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, Rossella Sartorius, Yasaman Esmaeili, Hamid Goodarzi, Matineh Ghomi, Ashkan Bigham, Farnaz Dabbagh Moghaddam, Maryam Heidarifard et al. · 2023 · Journal of Nanobiotechnology
  83. Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
    Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, Partha Sarathi Ghosh, Saroj Kumar Das · 2023 · European Journal of Medicinal Chemistry Reports
  84. How SARS-CoV-2 makes the cut
    Markus Hoffmann, Stefan Pöhlmann · 2021 · Nature Microbiology
  85. Can SARS-CoV-2 infect the eye? An overview of the receptor status in ocular tissue
    Sven Schnichels, Jens Martin Rohrbach, Tarek Bayyoud, Sebastian Thaler, Focke Ziemssen, José Hurst · 2020 · Der Ophthalmologe
  86. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective
    Wei Li · 2020 · Biophysical Chemistry
  87. Renin Angiotensin System, COVID-19 and Male Fertility: Any Risk for Conceiving?
    Lorella Pascolo, Gabriella Zito, Luisa Zupin, Stefania Luppi, Elena Giolo, Monica Martinelli, Daniela De Rocco, Sérgio Crovella, Giuseppe Ricci · 2020 · Microorganisms
  88. Virus‐Free and Live‐Cell Visualizing SARS‐CoV‐2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors
    Yali Zhang, Shaojuan Wang, Yangtao Wu, Wangheng Hou, Lunzhi Yuan, Chenguang Shen, Juan Wang, Jianghui Ye, Qingbing Zheng, Jian Ma et al. · 2020 · Small Methods
  89. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
    Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Walhan Alshaer, Engku Nur Syafirah Engku Abd Rahman, Manali Haniti Mohd-Zahid, Dina M. Alhaj-Qasem, Chan Yean Yean, Iskandar Zulkarnain Alias, Juhana Jaafar, Khalid Ferji et al. · 2021 · European Journal of Pharmacology
  90. Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
    Asim Z. Abbasi, Dania A. Kiyani, Syeda M. Hamid, Muhammad Saalim, Ammad Fahim, Nasir Jalal · 2021 · Journal of Medical Virology
  91. A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2
    Francis K. Yoshimoto · 2021 · The Protein Journal
  92. Effective chimeric antigen receptor T cells against SARS-CoV-2
    Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, Horacio Uri Saragovi, Christopher E. Rudd · 2021 · iScience
  93. Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection
    Takashi Tanikawa, Tsuyoshi Hayashi, Ryuichiro Suzuki, Masashi Kitamura, Yutaka Inoue · 2021 · Journal of Traditional and Complementary Medicine
  94. SARS‐CoV‐2 cellular tropism and direct multiorgan failure in COVID‐19 patients: Bioinformatic predictions, experimental observations, and open questions
    Anna A. Valyaeva, Anastasia A. Zharikova, Eugene V. Sheval · 2022 · Cell Biology International
  95. O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern
    Edgar González-Rodríguez, Mia I. Zol-Hanlon, Ganka Bineva‐Todd, Andrea Marchesi, Mark J. Skehel, Keira E. Mahoney, Chloë Roustan, Annabel Borg, Lucia Di Vagno, Svend Kjær et al. · 2023 · ACS Central Science
  96. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
    Nina Reuter, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla, Marco Thomas · 2023 · Viruses
  97. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2
    Biering, Scott B., Van Dis, Erik, Wehri, Eddie, Yamashiro, Livia H., Wrynla, Xammy Huu, Dugast-Darzacq, Claire, Graham, Thomas G. W., Stroumza, Julien R., Golovkine, Guillaume R., Roberts, Allison W. et al. · 2021 · ACS Infectious Diseases
  98. Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
    Günl, Franziska, Mecate-Zambrano, Angeles, Rehländer, Selina, Hinse, Saskia, Ludwig, Stephan, Brunotte, Linda · 2021 · Vaccines
  99. Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies
    Ying Li, Shanglong Liu, Shuchao Zhang, Qiang Ju, Shaoqiang Zhang, Yuanming Yang, Haiyan Wang · 2020 · Transfusion and Apheresis Science
  100. Union is strength: antiviral and anti-inflammatory drugs for COVID-19
    J. Jesús Naveja, Abraham Madariaga‐Mazón, Francisco Javier Flores‐Murrieta, Julio Granados‐Montiel, Marco Antonio Maradiaga-Ceceña, Víctor Duarte-Alaniz, Maricruz Maldonado-Rodriguez, Jazmín García-Morales, Juan P. Senosiain, Karina Martínez‐Mayorga · 2020 · Drug Discovery Today